Rare diseases
Investigational molecules
Locations
Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
LithuaniaStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
LithuaniaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
LithuaniaStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
LithuaniaStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
LithuaniaStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
LithuaniaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis
LithuaniaStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
LithuaniaStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
LithuaniaStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
LithuaniaStudy on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
LithuaniaStudy on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis
LithuaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
